SM
Sofinnova MD Start IV
Undisclosed · Healthtech
Medtech venture fund creating companies around clinical needs in Europe and the US.
Product
Sofinnova MD Start IV funds the creation of medical technology companies, working with clinicians, engineers and scientists to turn ideas into businesses. Its team combines capital with operational support from inception through clinical and organisational milestones.
Managed by Sofinnova Partners, the fund plans to launch six to eight ventures across Europe and the US over five years. It reached an oversubscribed €82 million final close in September 2026, extending the manager’s company-building strategy.
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Medtech venture fund final close | €82M | Participants not disclosed |